Cited by 868Bipolar Disorder and TreatmentWorkplace Health and Well-beingMental Health Treatment and Access

Prevalence and Effects of Mood Disorders on Work Performance in a Nationally Representative Sample of U.S. Workers

Open access
Kessler, Ronald C., Akiskal, Hagop S., Ames, Minnie, Birnbaum, Howard, Greenberg, Paul, .A, Robert M, Jin, Robert, Merikangas, Kathleen R. +2 more·2006·American Journal of Psychiatry

Abstract

Objective: Research on the workplace costs of mood disorders has focused largely on major depressive episodes. Bipolar disorder has been overlooked both because of the failure to distinguish between major depressive disorder and bipolar disorder and by the failure to evaluate the workplace costs of mania/hypomania. Method: The National Comorbidity Survey Replication assessed major depressive disorder and bipolar disorder with the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI) and work impairment with the WHO Health and Work Performance Questionnaire. A regression analysis of major depressive disorder and bipolar disorder predicting Health and Work Performance Questionnaire scores among 3,378 workers was used to estimate the workplace costs of mood disorders. Results: A total of 1.1% of the workers met CIDI criteria for 12-month bipolar disorder (I or II), and 6.4% meet criteria for 12-month major depressive disorder. Bipolar disorder was associated with 65.5 and major depressive disorder with 27.2 lost workdays per ill worker per year. Subgroup analysis showed that the higher work loss associated with bipolar disorder than with major depressive disorder was due to more severe and persistent depressive episodes in those with bipolar disorder than in those with major depressive disorder rather than to stronger effects of mania/hypomania than depression. Conclusions: Employer interest in workplace costs of mood disorders should be broadened beyond major depressive disorder to include bipolar disorder. Effectiveness trials are needed to study the return on employer investment of coordinated programs for workplace screening and treatment of bipolar disorder and major depressive disorder.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/ajp.2006.163.9.1561

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Among people occupying social and productive roles, major depressive disorder predicts substantial declines in role functioning, including poorer marital quality, lower work performance, and lower earnings.

    “Among people with specific social and productive roles, MDD is found to predict significant decrements in role functioning (e.g., low marital quality, low work performance, low earnings).”

    From The Costs of Depression (2012) · cites this paper as [64]

  • Major depressive episode and major depressive disorder significantly predict overall lost work performance, with annual salary-equivalent human capital value estimates between $30.1 billion and $51.5 billion.

    “All these studies found that MDE and MDD significantly predict overall lost work performance. Several studies attempted to estimate the annual salary-equivalent human capital value of these losses. These estimates were in the range $30.1 billion66 to $51.5 billion.64”

    From The Costs of Depression (2012) · cites this paper as [64]

  • Impaired cognition is likely associated with difficulties in everyday tasks, contributing to psychosocial and functional impairments, reduced productivity, and disability in major depressive disorder.

    “Impaired cognition is likely associated with difficulties in everyday tasks contributing to the high degree of psychosocial and functional impairments [6–8], reduced productivity [9], and disability associated with MDD [10, 11].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [11]Greenberg PE, Kessler RC, Nells TL, Finkelstein SN, Berndt ER. Depression in the workplace: An economic perspective, in Perspectives in Psychiatry: Selective Serotonin Re-uptake Inhibitors. In: Feighner JP, Boyer WF, editors. Advances in Basic Research and Clinical Practice. 2. Vol. 5. New York: John Wiley & Sons, Inc; 1996. pp. 327–363. [Google Scholar]
  2. [22]First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP) New York, NY: Biometrics Research, New York State Psychiatric Institute; 2002. [Google Scholar]
  3. [29]Research Triangle Institute. SUDAAN: Professional Software for Survey Data Analysis [computer program] Research Triangle Park, N.C: Research Triangle Institute; 2002. [Google Scholar]

Cited by

Sorted by citations

Authors
Kessler, R. C., Akiskal, H. S., Ames, M., Birnbaum, H., Greenberg, P., .A, R. M., Jin, R., Merikangas, K. R., Simon, G. E., & Wang, P. S.
Affiliations
Harvard University (US)
Venue
American Journal of Psychiatry
Published
2006-09
Volume
163
Issue
9
Pages
1561-1568
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2120839478
Cited by
868
References
47
Citations by year
2026: 13 · 2025: 16 · 2024: 25 · 2023: 29 · 2022: 20 · 2021: 34 · 2020: 38 · 2019: 56 · 2018: 50 · 2017: 53 · 2016: 60 · 2015: 59 · 2014: 52 · 2013: 64 · 2012: 60
FWCI
27.68
Type
journal article
Language
en
Open access
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • John D. and Catherine T. MacArthur Foundation (R01 DA016558)
  • John W. Alden Trust
  • Eli Lilly and Company
  • Pfizer
  • GlaxoSmithKline
  • World Health Organization
  • Harvard University
  • Michigan State University
  • Johns Hopkins University
  • University of Pittsburgh
  • National Institutes of Health (5r13mh066849-04, 5r01mh069864-04)
  • Substance Abuse and Mental Health Services Administration
  • College of Engineering, Michigan State University
  • Pfizer Foundation (R01‐MH069864, R01-DA016558)
  • Pan American Health Organization
  • National Institute of Mental Health (R13-MH-066849, U01-MH-60220, MH60220, U13MH066849, U01MH060220, R01‐MH069864)
  • National Institute on Drug Abuse (K05DA015799, R01DA016558)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Health Professions › General Health Professions › Workplace Health and Well-being
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
Keywords
mood disorders, bipolar disorder, major depressive disorder, employee performance, work impairment, lost workdays, mania, hypomania, prevalence
MeSH terms
Absenteeism, Adolescent, Adult, Bipolar Disorder, Costs and Cost Analysis, Major Depressive Disorder, Depressive Disorder, Major, Efficiency, Female, Humans, Male, Middle Aged, Occupations, Psychiatric Status Rating Scales, Surveys and Questionnaires, Task Performance and Analysis, United States, Work, Comorbidity, Prevalence, Workplace, Mood Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review